186 related articles for article (PubMed ID: 15880942)
1. Sustained extracellular signal-regulated kinase1/2 mitogen-activated protein kinase signalling is related to increased p21 expression in cholesteatoma epithelium.
Huisman MA; De Heer E; Grote JJ
Acta Otolaryngol; 2005 Feb; 125(2):134-40. PubMed ID: 15880942
[TBL] [Abstract][Full Text] [Related]
2. Terminal differentiation and mitogen-activated protein kinase signaling in human cholesteatoma epithelium.
Huisman MA; De Heer E; Grote JJ
Otol Neurotol; 2006 Apr; 27(3):422-6. PubMed ID: 16639284
[TBL] [Abstract][Full Text] [Related]
3. Survival signaling and terminal differentiation in cholesteatoma epithelium.
Huisman MA; De Heer E; Grote JJ
Acta Otolaryngol; 2007 Apr; 127(4):424-9. PubMed ID: 17453465
[TBL] [Abstract][Full Text] [Related]
4. Cholesteatoma epithelium is characterized by increased expression of Ki-67, p53 and p21, with minimal apoptosis.
Huisman MA; De Heer E; Grote JJ
Acta Otolaryngol; 2003 Apr; 123(3):377-82. PubMed ID: 12737294
[TBL] [Abstract][Full Text] [Related]
5. Asperolide A, a marine-derived tetranorditerpenoid, induces G2/M arrest in human NCI-H460 lung carcinoma cells, is mediated by p53-p21 stabilization and modulated by Ras/Raf/MEK/ERK signaling pathway.
Lv C; Sun W; Sun H; Wei S; Chen R; Wang B; Huang C
Mar Drugs; 2013 Jan; 11(2):316-31. PubMed ID: 23434831
[TBL] [Abstract][Full Text] [Related]
6. UCN-01-induced cell cycle arrest requires the transcriptional induction of p21(waf1/cip1) by activation of mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway.
Facchinetti MM; De Siervi A; Toskos D; Senderowicz AM
Cancer Res; 2004 May; 64(10):3629-37. PubMed ID: 15150122
[TBL] [Abstract][Full Text] [Related]
7. Sustained activation of Ras/Raf/mitogen-activated protein kinase cascade by the tumor suppressor p53.
Lee SW; Fang L; Igarashi M; Ouchi T; Lu KP; Aaronson SA
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8302-5. PubMed ID: 10890907
[TBL] [Abstract][Full Text] [Related]
8. Noncatalytic function of ERK1/2 can promote Raf/MEK/ERK-mediated growth arrest signaling.
Hong SK; Yoon S; Moelling C; Arthan D; Park JI
J Biol Chem; 2009 Nov; 284(48):33006-18. PubMed ID: 19805545
[TBL] [Abstract][Full Text] [Related]
9. Requirement for Ras/Raf/ERK pathway in naringin-induced G1-cell-cycle arrest via p21WAF1 expression.
Kim DI; Lee SJ; Lee SB; Park K; Kim WJ; Moon SK
Carcinogenesis; 2008 Sep; 29(9):1701-9. PubMed ID: 18296682
[TBL] [Abstract][Full Text] [Related]
10. Induction of p21 and p27 expression by amino acid deprivation of HepG2 human hepatoma cells involves mRNA stabilization.
Leung-Pineda V; Pan Y; Chen H; Kilberg MS
Biochem J; 2004 Apr; 379(Pt 1):79-88. PubMed ID: 14715082
[TBL] [Abstract][Full Text] [Related]
11. Oxidant species are involved in T/B-mediated ERK1/2 phosphorylation that activates p53-p21 axis to promote KSHV lytic cycle in PEL cells.
Gonnella R; Yadav S; Gilardini Montani MS; Granato M; Santarelli R; Garufi A; D'Orazi G; Faggioni A; Cirone M
Free Radic Biol Med; 2017 Nov; 112():327-335. PubMed ID: 28801242
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.
Wen-Sheng W
Cancer Lett; 2006 Jul; 239(1):27-35. PubMed ID: 16169661
[TBL] [Abstract][Full Text] [Related]
13. Antiproliferative autoantigen CDA1 transcriptionally up-regulates p21(Waf1/Cip1) by activating p53 and MEK/ERK1/2 MAPK pathways.
Tu Y; Wu W; Wu T; Cao Z; Wilkins R; Toh BH; Cooper ME; Chai Z
J Biol Chem; 2007 Apr; 282(16):11722-31. PubMed ID: 17317670
[TBL] [Abstract][Full Text] [Related]
14. Loss of oncogenic H-ras-induced cell cycle arrest and p38 mitogen-activated protein kinase activation by disruption of Gadd45a.
Bulavin DV; Kovalsky O; Hollander MC; Fornace AJ
Mol Cell Biol; 2003 Jun; 23(11):3859-71. PubMed ID: 12748288
[TBL] [Abstract][Full Text] [Related]
15. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
16. The role of p21 and p53 proteins in congenital cholesteatoma.
Olszewska E; Rutkowska J; Minovi A; Sieskiewicz A; Rogowski M; Dazert S
Otol Neurotol; 2013 Feb; 34(2):266-74. PubMed ID: 23324739
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic inhibition of RAF-->MEK-->ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1.
Gysin S; Lee SH; Dean NM; McMahon M
Cancer Res; 2005 Jun; 65(11):4870-80. PubMed ID: 15930308
[TBL] [Abstract][Full Text] [Related]
18. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
Zhang YX; Kong CZ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
[TBL] [Abstract][Full Text] [Related]
19. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases.
Touyz RM; Yao G
J Cell Physiol; 2003 Dec; 197(3):326-35. PubMed ID: 14566962
[TBL] [Abstract][Full Text] [Related]
20. Sustained activation of the extracellular signal-regulated kinase pathway protects cells from photofrin-mediated photodynamic therapy.
Tong Z; Singh G; Rainbow AJ
Cancer Res; 2002 Oct; 62(19):5528-35. PubMed ID: 12359764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
